These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6613830)

  • 41. Amiodarone pharmacokinetics in coronary patients: differences between acute and one-month chronic dosing.
    Poirier JM; Escoubet B; Jaillon P; Coumel P; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1988; 13(1):67-72. PubMed ID: 3396616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of plasma, white blood cell, red blood cell, and tissue distribution of amiodarone and desethylamiodarone in anesthetized dogs.
    Bandyopadhyay S; Somani P
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):379-88. PubMed ID: 2444790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
    Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K
    J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats.
    Wyss PA; Moor MJ; Bickel MH
    J Pharmacol Exp Ther; 1990 Aug; 254(2):502-7. PubMed ID: 2384884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of the clinical pharmacokinetics of amiodarone.
    Paton DM; Webster DR; Neutze JM
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):41-9. PubMed ID: 6371407
    [No Abstract]   [Full Text] [Related]  

  • 46. [Amiodarone therapy--behavior of serum and fatty tissue concentrations].
    Gonska BD; Bethge KP; Wagner H; Bosse K; Köbberling J; Quentin CD; Kreuzer H
    Klin Wochenschr; 1986 Mar; 64(5):219-26. PubMed ID: 3702280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma amiodarone concentrations during intravenous infusion.
    Watt AH; Hutchings A; Stephens MR; Routledge PA
    Br J Clin Pharmacol; 1986 May; 21(5):525-8. PubMed ID: 3718809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations.
    Storey GC; Holt DW; Holt P; Curry PV
    Ther Drug Monit; 1982; 4(4):385-8. PubMed ID: 7157462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absolute bioavailability of amiodarone in normal subjects.
    Pourbaix S; Berger Y; Desager JP; Pacco M; Harvengt C
    Clin Pharmacol Ther; 1985 Feb; 37(2):118-23. PubMed ID: 3967454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
    Adams PC; Holt DW; Storey GC; Morley AR; Callaghan J; Campbell RW
    Circulation; 1985 Nov; 72(5):1064-75. PubMed ID: 3930086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myocardium and plasma levels of amiodarone and its N-monodeethylated metabolite].
    Marchiset D; Egre A; Baille Y; Cano JP; Serradimigni A
    Therapie; 1983; 38(1):114-5. PubMed ID: 6867994
    [No Abstract]   [Full Text] [Related]  

  • 53. Amiodarone pharmacokinetics.
    Holt DW; Tucker GT; Jackson PR; McKenna WJ
    Br J Clin Pract Suppl; 1986 Apr; 44():109-14. PubMed ID: 3089248
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
    Shayeganpour A; Hamdy DA; Brocks DR
    Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
    Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
    Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary sequestration of amiodarone and desethylamiodarone.
    Camus P; Mehendale HM
    J Pharmacol Exp Ther; 1986 Jun; 237(3):867-73. PubMed ID: 3712283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of amiodarone and its N-deethylated metabolite in serum by high-performance liquid chromatography.
    Mostow ND; Noon DL; Myers CM; Rakita L; Blumer JL
    J Chromatogr; 1983 Oct; 277():229-37. PubMed ID: 6643608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liquid-chromatographic determination of amiodarone and its desethyl metabolite in plasma.
    Shipe JR
    Clin Chem; 1984 Jul; 30(7):1259. PubMed ID: 6733909
    [No Abstract]   [Full Text] [Related]  

  • 60. Amiodarone-associated changes in human neutrophils.
    Somani P; Simon VA; Temesy-Armos PN; Gross SA; Didio LJ
    Am J Cardiol; 1986 Mar; 57(8):666-72. PubMed ID: 3953455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.